L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

US9035044B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9035044-B2
Application numberUS-201213466249-A
CountryUS
Kind codeB2
Filing dateMay 8, 2012
Priority dateMay 9, 2011
Publication dateMay 19, 2015
Grant dateMay 19, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing said co-crystals and their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.

First claim

Opening claim text (preview).

What is claimed: 1. An L-proline co-crystal of a compound of formula (I-X) 2. The L-proline co-crystal as in claim 1 , comprising the following pXRD peaks °2θ: 3.74, 9.50, 10.98, 17.78, 18.62, 21.94, 23.43 and 26.82; wherein the pXRD peaks are measured using Cu/K g λ1.54056Å radiation. 3. The L-proline co-crystal as in claim 1 , wherein the co-crystal exhibits a melting point of 188° C., as measured by DSC. 4. A citric acid co-crystal of a compound of formula (I-X) 5. The citric acid co-crystal as in claim 4 , comprising the following pXRD peaks °2θ: 4.2, 9.16, 12.39, 16.54, 17.69, 19.70, 23.63 and 25.66 wherein the pXRD peaks are measured using Cu/K α λ1.54056Å radiation. 6. The citric acid co-crystal as in claim 4 , wherein the co-crystal exhibits a melting point of about 156° C., as measured by DSC.

Assignees

Inventors

Classifications

  • for hyperglycaemia, e.g. antidiabetics · CPC title

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • C07D409/10Primary

    linked by a carbon chain containing aromatic rings · CPC title

  • Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • Tricarboxylic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9035044B2 cover?
The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing said co-crystals and their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.
Who is the assignee on this patent?
Nguyen Minh, Collier Edwin A, Janssen Pharmaceutica Nv
What technology area does this patent fall under?
Primary CPC classification C07D409/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).